Peter Moesta
biomedicine
Harbour BioMed
China
Biography
CEO, Adello Biologics, LLC Previously, Senior VP of Biologics Development and Operations at Bristol-Myers Squibb. Oversaw the development, production and worldwide launch of Opdivo® (novlumab) and Yervoy® (ipilimumab) VP of Biologics Manufacturing for Abbott Laboratories, guided the manufacturing process and led the CMC effort to obtain approval for Humira® VP of Biologics Process Development and Operations for BASF Bioresearch Corporation PhD in Biochemistry from the University of Freiburg in Germany
Research Interest
Biologics
